Cargando…
Repurposing Doxepin to Ameliorate Steatosis and Hyperglycemia by Activating FAM3A Signaling Pathway
Mitochondrial protein FAM3A suppresses hepatic gluconeogenesis and lipogenesis. This study aimed to screen drug(s) that activates FAM3A expression and evaluate its effect(s) on hyperglycemia and steatosis. Drug-repurposing methodology predicted that antidepressive drug doxepin was among the drugs th...
Autores principales: | Chen, Zhenzhen, Liu, Xiangyang, Luo, Yanjin, Wang, Junpei, Meng, Yuhong, Sun, Lei, Chang, Yongsheng, Cui, Qinghua, Yang, Jichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243289/ https://www.ncbi.nlm.nih.gov/pubmed/32312868 http://dx.doi.org/10.2337/db19-1038 |
Ejemplares similares
-
FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice
por: Chen, Zhenzhen, et al.
Publicado: (2017) -
FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress
por: Chen, Zhenzhen, et al.
Publicado: (2017) -
FAM3C‐YY1 axis is essential for TGFβ‐promoted proliferation and migration of human breast cancer MDA‐MB‐231 cells via the activation of HSF1
por: Yang, Weili, et al.
Publicado: (2019) -
Comparison Analysis of Dysregulated LncRNA Profile in Mouse Plasma and Liver after Hepatic Ischemia/Reperfusion Injury
por: Chen, Zhenzhen, et al.
Publicado: (2015) -
Intracellular ATP Signaling Contributes to FAM3A-Induced PDX1
Upregulation in Pancreatic Beta Cells
por: Yan, Han, et al.
Publicado: (2021)